Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesComparison of Combined Bupropion and Naltrexone Therapy for Obesity with Monotherapy and Placebo
Journal of Clinical Endocrinology and Metabolism, 10/29/09
Greenway FL et al. – NB caused gradual sustained weight loss over 48 wk; NB32 and NB16 demonstrated greater weight loss in the intent–to–treat population due to lower attrition rates. Further study is needed to demonstrate long–term efficacy and safety of NB.
Today in Obesity...keeping you current
Receive free subspecialty "5-minute updates" via email
An integrative view of obesity
American Journal of Clinical Nutrition, 11/19/09
Marine Omega-3 Fatty Acid Intake: Associations with Cardiometabolic Risk and Response to Weight Loss Intervention in The Look AHEAD Study
Diabetes Care, 11/05/09
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
The Lancet, 11/09/09
Sponsor
Article Search
Sponsor